Angiotensin‐converting enzyme inhibitors vs placebo
CVD events: total (fatal and non‐fatal) · adults with early (stage 1 to 3) non‐diabetic CKD
Angiotensin‐converting enzyme inhibitors showed no clear difference in CVD events: total (fatal and non‐fatal) compared with placebo (low certainty).
1 finding from 1 review
- Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3)… 2023 · Cochrane Headline outcomes onlyRR 0.97 [0.9, 1.05]2 studies · 8873 participantsLow